Hypnotherapy for irritable bowel syndrome: streamlining provisio

Not Applicable

Completed

• Conditions: Irritable bowel syndrome; Digestive System

• Registration Number: ISRCTN61738583
• Lead Sponsor: ational Institute for Health Research (UK)

Brief Summary

2015 results presented at DDW 2015 https://www.gastrojournal.org/article/S0016-5085(15)32244-7/abstract

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-01-10
• Study Completion: 2013-03-20
• Last Update Posted: 30 July 2018

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

1. Patients with refractory irritable bowel syndrome who are referred to the unit for hypnotherapy are eligible for this trial
2. Those with no other significant concomitant disease and agreeing to the study, having read the patient information details will be randomised to either of the treatment groups

Exclusion Criteria

Any significant concomitant disease that could interfere with the interpretation of the results

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Combined global outcome score and symptom severity scores

Secondary Outcome Measures

Name	Time	Method
1. Hospital Anxiety and Depression score<br>2. Quality of life score<br>3. Non colonic symptom score<br>4. EQ5D